KLH in Clinical Trials

Clinical trials involving KLH. Details such as study status, design and investigators are available by link to outside sites.

Clinical trial links are intended for informational purposes only, and are not solicitations for any study nor provided for the purposes of giving medical advice. See Terms of Use for this site.

(in order by date)

Entries in KLH-WT1 (3)

Wednesday
Jun172009

NCT00923910

Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

Conditions: Acute Myelogenous (AML), Acute Lymphocytic (ALL), Chronic Myelogenous (CML), Myelodysplastic Syndrome (MDS), Non-Hodgkin's Lymphoma (NHL)
Sponsors: National Cancer Institute (NCI)
Phase I, II

Thursday
Sep082005

NCT00153608

WT1 Peptide Vaccination in Carcinomas

Conditions: WT1 Expressing Carcinoma
Sponsors: Charite University, Berlin, Germany
Phase II

Thursday
Sep082005

NCT00153582

WT1 Peptide Vaccination in Acute Myeloid Leukemia (AML)

Conditions: Acute Myeloid Leukemia, Myelodysplastic Syndrome
Sponsors: Charite University, Berlin, Germany
Phase II